|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,310,000,000 |
Market
Cap: |
72.25(B) |
Last
Volume: |
37,878,742 |
Avg
Vol: |
7,672,242 |
52
Week Range: |
$55.15 - $81.42 |
|
Level
I Sector: |
Consumer Discretionary |
Level
II Sector: |
Retail |
Level
III Sector: |
Drug Stores |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : 7.4 |
Insider 3/6 Months : 8 |
|
Guru Rank Number : 214 |
Guru Rank Value : 5.7 |
Guru Occurances : 5 |
|
|
|
|
|
|
|
Company Profile CVS Health is a health solutions company. Co.'s segments include:Health Care Benefits, which provides voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, and dental and behavioral health plans; Pharmacy Services, which provides pharmacy benefit management solutions, including plan design offerings and administration, formulary management, and retail pharmacy network management services; and Retail/Long-Term Care (LTC), which sells prescription drugs and various health and wellness products and general merchandise, provides health care services through its MinuteClinic® walk-in medical clinics and conducts LTC pharmacy operations.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
2,000 |
16,000 |
16,000 |
Total Buy Value |
$0 |
$140,930 |
$1,117,497 |
$1,117,497 |
Total People Bought |
0 |
1 |
2 |
2 |
Total Buy Transactions |
0 |
1 |
2 |
2 |
Total Shares Sold |
29,473 |
29,473 |
55,232 |
484,338 |
Total Sell Value |
$2,267,947 |
$2,267,947 |
$4,197,951 |
$46,038,227 |
Total People Sold |
1 |
1 |
2 |
5 |
Total Sell Transactions |
1 |
1 |
2 |
7 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Shah Prem S |
EVP and Co-President of Retail |
|
2022-04-08 |
4 |
OE |
$54.19 |
$862,145 |
D/D |
13,824 |
50,686 |
|
- |
|
Finke Daniel P |
EVP/Pres, Health Care Benefits |
|
2022-04-05 |
4 |
AS |
$100.00 |
$594,100 |
D/D |
(5,941) |
32,150 |
|
7% |
|
Finke Daniel P |
EVP/Pres, Health Care Benefits |
|
2022-04-04 |
4 |
AS |
$100.13 |
$5,543,097 |
D/D |
(55,359) |
38,091 |
|
6% |
|
Finke Daniel P |
EVP/Pres, Health Care Benefits |
|
2022-04-04 |
4 |
OE |
$54.19 |
$2,460,629 |
D/D |
43,327 |
77,289 |
|
- |
|
Brennan Troyen A |
EVP and Chief Medical Officer |
|
2022-04-03 |
4 |
D |
$101.09 |
$220,275 |
D/D |
(2,179) |
232,676 |
|
- |
|
Moriarty Thomas M |
EVP & General Counsel |
|
2022-04-03 |
4 |
D |
$101.09 |
$359,476 |
D/D |
(3,556) |
735,349 |
|
- |
|
Rohan Karen |
President and CEO |
|
2022-04-01 |
4 |
D |
$101.09 |
$11,821,465 |
D/D |
(116,940) |
210,090 |
|
- |
|
Finke Daniel P |
EVP/Pres, Health Care Benefits |
|
2022-04-01 |
4 |
D |
$101.09 |
$1,757,753 |
D/D |
(17,388) |
50,123 |
|
- |
|
Brennan Troyen A |
EVP and Chief Medical Officer |
|
2022-04-01 |
4 |
D |
$101.09 |
$7,880,976 |
D/D |
(77,960) |
234,855 |
|
- |
|
Clark James David |
SVP, Cont & Chief Acct Officer |
|
2022-04-01 |
4 |
A |
$101.09 |
$324,903 |
D/D |
3,214 |
12,824 |
|
- |
|
Clark James David |
SVP, Cont & Chief Acct Officer |
|
2022-04-01 |
4 |
D |
$101.09 |
$670,934 |
D/D |
(6,637) |
26,330 |
|
- |
|
Lotvin Alan |
EVP&President-PharmacyServices |
|
2022-04-01 |
4 |
D |
$101.09 |
$3,854,461 |
D/D |
(38,129) |
109,183 |
|
- |
|
Moriarty Thomas M |
EVP & General Counsel |
|
2022-04-01 |
4 |
D |
$101.09 |
$10,700,781 |
D/D |
(105,854) |
730,897 |
|
- |
|
Shah Prem S |
EVP and Co-President of Retail |
|
2022-04-01 |
4 |
D |
$101.09 |
$2,272,301 |
D/D |
(22,478) |
46,583 |
|
- |
|
Shah Prem S |
EVP and Co-President of Retail |
|
2022-03-30 |
4 |
AS |
$104.70 |
$559,726 |
D/D |
(5,346) |
59,071 |
|
0% |
|
Shah Prem S |
EVP and Co-President of Retail |
|
2022-03-30 |
4 |
OE |
$102.26 |
$546,682 |
D/D |
5,346 |
64,417 |
|
- |
|
Shah Prem S |
EVP and Co-President of Retail |
|
2022-03-17 |
4 |
S |
$106.65 |
$493,150 |
D/D |
(4,624) |
59,071 |
|
12% |
|
Shah Prem S |
EVP and Co-President of Retail |
|
2022-03-17 |
4 |
OE |
$104.82 |
$307,647 |
D/D |
2,935 |
62,006 |
|
- |
|
Moriarty Thomas M |
EVP & General Counsel |
|
2022-03-15 |
4 |
OE |
$102.26 |
$5,252,176 |
D/D |
51,361 |
888,112 |
|
- |
|
Moriarty Thomas M |
EVP & General Counsel |
|
2022-03-15 |
4 |
AS |
$105.00 |
$5,392,905 |
D/D |
(51,361) |
836,751 |
|
-12% |
|
Clark James David |
SVP, Cont & Chief Acct Officer |
|
2022-02-28 |
4 |
D |
$103.65 |
$45,191 |
D/D |
(436) |
26,668 |
|
- |
|
Shah Prem S |
EVP and Co-President of Retail |
|
2022-02-28 |
4 |
D |
$103.65 |
$14,615 |
D/D |
(141) |
60,760 |
|
- |
|
Peluso Michelle A |
EVP and Co-President of Retail |
|
2022-02-26 |
4 |
D |
$104.30 |
$1,315,119 |
D/D |
(12,609) |
14,911 |
|
- |
|
Shah Prem S |
EVP and Co-President of Retail |
|
2022-02-26 |
4 |
D |
$104.30 |
$23,572 |
D/D |
(226) |
59,394 |
|
- |
|
Havanec Laurie P. |
EVP and Chief People Officer |
|
2022-02-26 |
4 |
D |
$104.30 |
$545,802 |
D/D |
(5,233) |
9,754 |
|
- |
|
711 Records found
|
|
Page 5 of 29 |
|
|